VRTX
Vertex Pharmaceuticals IncorporHealthcare$438.71
▲ Bullish
Mkt Cap: $111.45B|Float: 253.2M|SI: 1.6%|DTC: 2.9
Data as of market close Apr 2, 2026
IV Rank
0
IV Pctl
0%
HV 20d
3994.0%
52W Range
$363-$511
ATR(14)
$10.94
Exp. Move
±3.7%
P/C Ratio
0.82
Earnings
May 4
GEX Negative
DEX Long
Net Call Premium
IV Low
Max Pain Above
Exp. Move Moderate
VRTX Key Options Data
- IV Rank
- 0%
- Total GEX
- $-0.00B
- Total DEX
- $1.1M
- Max Pain
- $455.00
- Expected Move
- ±3.7%
- Put/Call OI
- 0.82
- Net Premium
- $3.2M
- Spot Price
- $438.71
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$16.05 | ±3.7% | $422.66 | $454.76 |
| 2026-04-17 | 15 | ±$20.65 | ±4.7% | $418.06 | $459.36 |
| 2026-04-24 | 22 | ±$25.05 | ±5.7% | $413.66 | $463.76 |
| 2026-05-01 | 29 | ±$12.50 | ±2.9% | $426.21 | $451.21 |
| 2026-05-08 | 36 | ±$19.25 | ±4.4% | $419.46 | $457.96 |
| 2026-05-15 | 43 | ±$20.30 | ±4.6% | $418.41 | $459.01 |
Explore VRTX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.